Stock EXEL EXELIXIS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Exelixis, Inc.

Equities

EXEL

US30161Q1040

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
20.57 USD +0.78% Intraday chart for Exelixis, Inc. -1.63% -14.26%
May. 20 Exelixis Settles Cabometyx Patent Litigation with Cipla MT
May. 14 Transcript : Exelixis, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 02:35 PM

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Exelixis Settles Cabometyx Patent Litigation with Cipla
MT
Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA
BU
Transcript : Exelixis, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 02:35 PM
Transcript : Exelixis, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM
Transcript : Exelixis, Inc. Presents at The Citizens JMP Life Sciences Conference, May-14-2024 09:30 AM
Stephens Initiates Exelixis With Equalweight Rating, $23 Price Target
MT
Exelixis Files Patent Complaint Against Cipla's Cancer Treatment
DJ
Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May
BU
RBC Trims Exelixis' Price Target to $27 From $28, Outperform Rating Kept
MT
Exelixis Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Maintained -- Shares Fall After Hours
MT
Transcript : Exelixis, Inc., Q1 2024 Earnings Call, Apr 30, 2024
Exelixis Guides For 2024 Revenue of $1.825-$1.925 Billion, vs CIQ Analyst Consensus of $1.91 Billion
MT
Earnings Flash (EXEL) EXELIXIS Reports Q1 Revenue $425.2M, vs. Street Est of $460.5M
MT
Earnings Flash (EXEL) EXELIXIS Reports Q1 EPS $0.17, vs. Street Est of $0.29
MT
Tranche Update on Exelixis, Inc.'s Equity Buyback Plan announced on January 8, 2024.
CI
Exelixis: Q1 Earnings Snapshot
AQ
Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update
BU
Exelixis, Inc. Reaffirms Earnings Guidance for the Year 2024
CI
Exelixis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. EXEL Stock
  4. News Exelixis, Inc.